The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

I gave my staff the week off (you might have caught me answering phones) – it has been that kind of year. Here is wishing all of you peace and a food safety New Year. I have been making candles ...

A driver involved in a tragic hit-and-run incident in Phuket turned himself into the police. Police confirmed that the driver will face charges for his actions following the fatal accident that ...